Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Orphan drug status for PI-88 for malignant melanoma

May 5, 2004

AMDL seeks partner for Combination Immunogene Therapy

May 5, 2004

Panacea collaborates with M.D. Anderson Cancer Center on HAAH program

May 5, 2004

MAGNET liver cancer trial stopped early

May 5, 2004

Interim results from phase II trial of Metastat

May 5, 2004

Celgene to stop Revlimid phase III trials in melanoma

May 4, 2004

New antiangiogenic agents in early development at Boehringer Ingelheim

May 4, 2004

Lilly claims TGF-beta receptor kinase inhibitors for cancer and other disorders

May 4, 2004

Antineoplastic effects of pioglitazone on malignant tumor growth in rat glioma model

May 4, 2004

Interim results for Theralux in NHL

May 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...